摘要
目的：观察疏血通联合替米沙坦治疗临床糖尿病肾病（DN）的疗效.方法：将58例2型DN患者随机分为对照组（替米沙坦）和治疗组（疏血通＋替米沙坦）.比较两组治疗前和治疗后2周BUN、Scr 和Upro、Gsp等指标的变化.结果：治疗后治疗组和对照组BUN、Scr 和Upro、Gsp等指标均显著下降（P〈0.05,P〈0.01）,治疗组比对照组下降更为明显（P〈0.05）.结论：疏血通和替米沙坦联合治疗能有效减少DN 患者的蛋白尿,改善肾功能.
Observe the purposes and blood for the clinical cure diabetes telmisartan the dn of the kidney （telmisartan）. method ： will cases randomly divided into two types of the dn （telmisartan） and for the treatment of lead and the blood （telmisartan）. compare two sets of treatment for two weeks before and after a bun, scr and upro, gsp and other indicators of changes, the treatment and treatment groups ： the bun, scr and upro, gsp and other indicators are down significantly （ P〈, 0. 05 P〈0. 01） and treatment groups than the greater the fall
